在炎症性肠病和原发性硬化胆管炎中导航瘤风险
Demis Pitoni1,2, Arianna Dal Buono1,3, Roberto Gabbiadini1
1IBD Center, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
Cancers
|July 12, 2025
概括
患有炎症性肠病 (IBD) 和原发性硬化性胆管炎 (PSC) 的患者患有结直肠癌 (CRC) 和胆管癌 (CCA) 的风险较高. 早期检测和先进的预防策略对于管理这一群体的癌症风险至关重要.
科学领域:
- 胃肠病学和肝病学 胃肠学和肝病学
- 在瘤学瘤学.
背景情况:
- 患有炎症性肠病 (IBD) 和原发性硬化性胆道炎 (PSC) 的患者显着增加结直肠癌 (CRC) 和胆管癌 (CCA) 的风险.
- 导致PSC-IBD患者癌症风险增加的精确分子机制尚未完全阐明.
- 本综述综合了有关癌症发展,诊断和预防的当前知识,在这个特定的患者队列.
研究的目的:
- 审查和整合最近关于原发性硬化胆管炎和炎症性肠病 (PSC-IBD) 患者癌症风险的研究结果.
- 专注于分子途径,诊断创新和预防策略,这些都与此种人群中的结直肠癌 (CRC) 和胆管癌 (CCA) 有关.
主要方法:
- 在PubMed进行了系统的文献搜索,截至2025年3月.
- 包括专注于瘤性过程,分子机制以及PSC-IBD患者CRC和CCA诊断和预防策略的进展的研究.
主要成果:
- 目前的监测包括每年对CRC进行结肠镜检查和对CCA进行CA 19-9监测的成像检查.
- 新兴研究表明,PSC-IBD的瘤发生过程中存在分子变化,例如表观遗传修饰.
- 分子诊断,成像和内镜技术的创新提高了癌症检测的准确性和效率.
结论:
- 患有PSC-IBD的人面临CRC和CCA的持续高风险,这强调了严格监测和积极预防的必要性.
- 早期检测和精确诊断方面的进步为减轻这一弱势群体癌症负担提供了重大机会.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
332
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
332
Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Inflammatory Bowel Disease II: Crohn's Disease
392
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
392
Inflammatory Bowel Disease V: Surgical Management
221
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
221
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
426
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
426
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
237
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
237


